Am J Health Syst Pharm. 2011;68(5):389-398.

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...

OBJECTIVES To study the efficacy of allopurinol and benzbromarone to reduce serum urate concentrations in patients with primary chronic gout. METHODS Prospective, parallel, open study of 86 ...

and tolerability of serum uric acid lowering and maintenance with febuxostat in patients with gout. Febuxostat Open-label Clinical Trial of Urate-lowering Efficacy and Safety Adverse events were ...

Some dietary habits are worse than others when it comes to gout risk for women, a large study indicated. Data from the two ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

High uric acid levels can result in gout or kidney disease. These are the two most common conditions related ... Over time, kidney stones and other forms of kidney damage can lead to chronic kidney ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

Doctors often focus on managing acute attacks rather than viewing gout as a chronic progressive crystal deposition disease. Urate-lowering treatment is underprescribed and often underdosed.